Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer

Kosei Yasumoto; Takeshi Ogura

doi:10.1007/bf02221327

Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer

Biotherapy ◽

10.1007/bf02221327 ◽

1991 ◽

Vol 3 (4) ◽

pp. 345-349 ◽

Cited By ~ 15

Author(s):

Kosei Yasumoto ◽

Takeshi Ogura

Keyword(s):

Lung Cancer ◽

Interleukin 2 ◽

Recombinant Interleukin 2 ◽

Malignant Pleurisy

Download Full-text

Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer

Oncology Reports ◽

10.3892/or.9.3.661 ◽

2002 ◽

Cited By ~ 1

Author(s):

Giovanni Mantovani ◽

Antonio Maccio ◽

Carlo Mulas ◽

Elena Massa ◽

Clelia Madeddu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Medroxyprogesterone Acetate ◽

Phase Ii Study ◽

Interleukin 2 ◽

Small Cell ◽

Small Cell Lung ◽

Recombinant Interleukin 2 ◽

Weekly Cisplatin

Download Full-text

Effect of postoperative intrapleural instillations of interleukin-2 in patients with malignant pleurisy due to lung cancer

Biotherapy ◽

10.1007/bf01877426 ◽

1993 ◽

Vol 6 (2) ◽

pp. 133-138 ◽

Cited By ~ 1

Author(s):

Kosei Yasumoto ◽

Akira Nagashima ◽

Hisashi Nakahashi ◽

Teruyoshi Ishida ◽

Keizo Sugimachi ◽

...

Keyword(s):

Lung Cancer ◽

Interleukin 2 ◽

Malignant Pleurisy

Download Full-text

Subcutaneous (s.c.) administration of recombinant interleukin 2 (r-IL2) in extensive small cell lung cancer (SCLC) in partial remission after induction chemotherapy

Cytokine ◽

10.1016/1043-4666(91)90321-4 ◽

1991 ◽

Vol 3 (5) ◽

pp. 495

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Partial Remission ◽

Interleukin 2 ◽

Small Cell ◽

Small Cell Lung ◽

Recombinant Interleukin 2

Download Full-text

Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells

Cellular Immunology ◽

10.1016/0008-8749(87)90165-1 ◽

1987 ◽

Vol 106 (2) ◽

pp. 215-222 ◽

Cited By ~ 14

Author(s):

Bruch W.S. Robinson ◽

George Morstyn

Keyword(s):

Lung Cancer ◽

Nk Cells ◽

Cancer Cells ◽

Natural Killer ◽

Human Lung ◽

Interleukin 2 ◽

Lung Cancer Cells ◽

Human Lung Cancer ◽

Human Lung Cancer Cells ◽

Recombinant Interleukin 2

Download Full-text

Results of a Dose-Intense Phase 1 Study of a Combination Chemotherapy Regimen With Cisplatin and Epidoxorubicin Including Medroxyprogesterone Acetate and Recombinant Interleukin-2 in Patients With Inoperable Primary Lung Cancer

Journal of Immunotherapy ◽

10.1097/00002371-200003000-00011 ◽

2000 ◽

Vol 23 (2) ◽

pp. 267-274 ◽

Cited By ~ 6

Author(s):

Giovanni Mantovani ◽

Antonio Macciò ◽

Paola Lai ◽

Elena Massa ◽

Daniela Massa ◽

...

Keyword(s):

Lung Cancer ◽

Combination Chemotherapy ◽

Medroxyprogesterone Acetate ◽

Chemotherapy Regimen ◽

Phase 1 ◽

Interleukin 2 ◽

Primary Lung Cancer ◽

Phase 1 Study ◽

Recombinant Interleukin 2 ◽

Combination Chemotherapy Regimen

Download Full-text

In vivo activation of eosinophil granulocytes by subcutaneous (s.c.) injection of recombinant interleukin 2 (IL2) in patients with small cell lung cancer (SCLC)

Cytokine ◽

10.1016/1043-4666(91)90315-5 ◽

1991 ◽

Vol 3 (5) ◽

pp. 494

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Interleukin 2 ◽

Small Cell ◽

Small Cell Lung ◽

Recombinant Interleukin 2 ◽

Eosinophil Granulocytes

Download Full-text

Complement activation during subcutaneous (s.c.) administration of recombinant interleukin 2 (IL2) in patients with small cell lung cancer (SCLC)

Cytokine ◽

10.1016/1043-4666(91)90325-8 ◽

1991 ◽

Vol 3 (5) ◽

pp. 496

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Complement Activation ◽

Interleukin 2 ◽

Small Cell ◽

Small Cell Lung ◽

Recombinant Interleukin 2

Download Full-text

Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer

International Journal of Cancer ◽

10.1002/ijc.2910430414 ◽

1989 ◽

Vol 43 (4) ◽

pp. 619-623 ◽

Cited By ~ 20

Author(s):

Tokujiro Yano ◽

Kosei Yasumoto ◽

Masatoshi Togami ◽

Teruyoshi Ishida ◽

Genki Kimura ◽

...

Keyword(s):

Lung Cancer ◽

Human Lung ◽

Interleukin 2 ◽

Tumor Infiltrating Lymphocytes ◽

Human Lung Cancer ◽

Recombinant Interleukin 2 ◽

Infiltrating Lymphocytes

Download Full-text

Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with Cisplatin (CDDP) and Epirubicin (EPI) including Medroxyprogesterone Acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer

Lung Cancer ◽

10.1016/s0169-5002(99)90787-0 ◽

1999 ◽

Vol 25 ◽

pp. S31

Author(s):

G. Mantovani ◽

A. Macciò ◽

P. Lai ◽

E. Massa ◽

M.C. Mudu ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Medroxyprogesterone Acetate ◽

Chemotherapy Regimen ◽

Phase Ii Study ◽

Interleukin 2 ◽

Primary Lung Cancer ◽

Recombinant Interleukin 2 ◽

Combination Chemotherapy Regimen

Download Full-text

Results of a dose-intense phase II study of a combination chemotherapy regimen with cisplatin (CDDP) and epirubicin (EPI) including medroxyprogesterone acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer

Lung Cancer ◽

10.1016/s0169-5002(00)80173-7 ◽

2000 ◽

Vol 29 (1) ◽

pp. 53

Author(s):

G Mantovani ◽

A Macciò ◽

E Massa ◽

M.C Mudu ◽

G Manca ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Medroxyprogesterone Acetate ◽

Chemotherapy Regimen ◽

Phase Ii Study ◽

Interleukin 2 ◽

Primary Lung Cancer ◽

Recombinant Interleukin 2 ◽

Combination Chemotherapy Regimen

Download Full-text